All lobbying filings

WALGREEN COMPANY

Lobbying for WALGREEN COMPANY

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $770,000.00 expenses · posted Apr 20, 2025

Official filing document

Bills named in this filing 1

HR 2484
Seniors’ Access to Critical Medications Act of 2025

Lobbying activity 3

Consumer Issues/Safety/Products

- Issues related to preventing organized retail crime

Taxation/Internal Revenue Code

- Issues related to tax reform

Pharmacy

- Issues related to access to pharmacist services - Issues related to increasing participation and diversity in clinical trials - Issues related to pharmacy benefit managers - H.R. 2484: Seniors Critical Access to Medications Act; issues related to pharmacist services - Issues related to 340B - Issues related to vaccine access

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.